Get started
Author

KellyAnn D. Pryor

Observed names: K A Pryor, K. D. Pryor, K. Pryor, Kelly Ann D. Pryor, Kelly Ann Pryor, Kelly D. Pryor, Kelly Pryor, KellyAnn D. PRYOR, Kellyann D. Pryor, Kellyann Pryor
OpenAlex ID: A5111591752
Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes
2005 · George R. Lankas, Barbara Leiting, et al. · Diabetes · 498
PDF
High-Level Expression of Soluble Protein inEscherichia coliUsing a His6-Tag and Maltose-Binding-Protein Double-Affinity Fusion System
1997 · Kellyann D. Pryor, Barbara Leiting · Protein Expression and Purification · 251
Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1
2010 · E M Migoya, R Bergeron, et al. · Clinical Pharmacology & Therapeutics · 178
Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII
2003 · Barbara LEITING, KellyAnn D. PRYOR, et al. · Biochemical Journal · 178
PDF
A comparative study of the binding properties, dipeptidyl peptidase‐4 ( DPP ‐4) inhibitory activity and glucose‐lowering efficacy of the DPP ‐4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice
2017 · Joel P. Berger, Ranabir SinhaRoy, et al. · Endocrinology Diabetes & Metabolism · 100
PDF
Discovery of Potent and Selective Dipeptidyl Peptidase IV Inhibitors Derived from β-Aminoamides Bearing Subsituted Triazolopiperazines
2008 · Dooseop Kim, Jennifer E. Kowalchick, et al. · Journal of Medicinal Chemistry · 63
Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: Close analogs of JANUVIA™ (sitagliptin phosphate)
2007 · Dooseop Kim, Jennifer E. Kowalchick, et al. · Bioorganic & Medicinal Chemistry Letters · 58
Design and Synthesis of Prolylcarboxypeptidase (PrCP) Inhibitors To Validate PrCP As A Potential Target for Obesity
2010 · Changyou Zhou, Margareta Garcia-Calvo, et al. · Journal of Medicinal Chemistry · 52
Inhibition of IMP-1 metallo-β-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives
1999 · Gail G. Hammond, Joann L. Huber, et al. · FEMS Microbiology Letters · 52
Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses
2009 · Kalpit A Vora, Gene Porter, et al. · BMC Immunology · 50
PDF
Design, synthesis, and biological evaluation of triazolopiperazine-based β-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors
2007 · Jennifer E. Kowalchick, Barbara Leiting, et al. · Bioorganic & Medicinal Chemistry Letters · 46
The Three-Dimensional Solution Structure of the SH2 Domain from p55blk Kinase
1996 · William J. Metzler, Barbara Leiting, et al. · Biochemistry · 26
Expression, purification and crystallization of human prolylcarboxypeptidase
2010 · Pravien D. Abeywickrema, Sangita B. Patel, et al. · Acta Crystallographica Section F Structural Biology and Crystallization Communications · 18
PDF
Inhibition of Dipeptidyl-Peptidase IV Does Not Increase Circulating IGF-1 Concentrations in Growing Pigs
2006 · T. D. Faidley, B. Leiting, et al. · Experimental Biology and Medicine · 17
One-Day Enzymatic Synthesis and Purification of UDP–N- [1-14C]Acetyl-Glucosamine
1998 · Barbara Leiting, KellyAnn D. Pryor, et al. · Analytical Biochemistry · 17
Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase
2010 · Xuemei Zhao, Katie Southwick, et al. · PROTEOMICS · 15
Soluble Penicillin-Binding Protein 2a: β-Lactam Binding and Inhibition by Non-β-Lactams Using a 96-Well Format
1998 · Jeffrey H. Toney, Gail G. Hammond, et al. · Analytical Biochemistry · 15
A high quality nuclear magnetic resonance solution structure of peptide deformylase from Escherichia coli: Application of an automated assignment strategy using GARANT
1999 · John F. O'Connell, KellyAnn D. Pryor, et al. · Journal of Biomolecular NMR · 14
Crystallization and preliminary X-ray analysis of the Escherichia coli UDP-MurNAc-tripeptide D -alanyl- D -alanine-adding enzyme (MurF)
1999 · Youwei Yan, Sanjeev Munshi, et al. · Acta Crystallographica Section D Biological Crystallography · 10
WITHDRAWN: Reprint of: High-Level Expression of Soluble Protein in Escherichia coli Using a His6-Tag and Maltose-Binding-Protein Double-Affinity Fusion System
2011 · KellyAnn D. Pryor, Barbara Leiting · Protein Expression and Purification · 3
Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase
2010 · Xuemei Zhao, Katie Southwick, et al. · PROTEOMICS - CLINICAL APPLICATIONS · 2
Purification, crystallization and preliminary X-ray analysis ofEscherichia coliUDP-N-acetylmuramoyl: L -alanine ligase (MurC)
2003 · Taru Deva, KellyAnn D. Pryor, et al. · Acta Crystallographica Section D Biological Crystallography · 1
Nmr Ensemble of Blk Sh2 Domain Using Chemical Shift Refinement, 20 Structures
1996 · W.J. Metzler, B. Leiting, et al. · Worldwide Protein Data Bank
Nmr Ensemble of Blk Sh2 Domain, 20 Structures
1996 · W.J. Metzler, B. Leiting, et al. · Worldwide Protein Data Bank
Works count: 24
Citation count: 1,664
H-index: 15
I10-index: 19
Year
Topic
Type